The Marketed Health Products Directorate (MHPD) is the Canadian federal authority that monitors the safety and effectiveness of health products marketed in Canada. These include:[1]
- Prescription and non-prescription medications
- Biologic medical products, including fractionated blood products
- Therapeutic and diagnostic vaccines
- Natural health products;
- Radiopharmaceutical products
- Medical devices
- Cells, tissues and organs
As part of Health Canada, MHPD collects and analyzes reports of adverse health product reactions through its network of regional reporting centres and disseminates new health product safety information.[2][3]
References edit
- ^ Health Canada (2008). "An Overview of the Marketed Health Products Directorate". Retrieved 28 February 2013.
- ^ Lexchin, Joel (2005). "Drug withdrawals from the Canadian market for safety reasons, 1963–2004". Canadian Medical Association Journal. March 15, 2005 vol. 172 no. 6 doi: 10.1503/cmaj.045021
- ^ Sibbald, Barbara (2002). "Health Canada targets postmarket surveillance of drugs". Canadian Medical Association Journal, June 11, 2002 vol. 166 no. 12
External links edit
- Marketed Health Products Directorate (official website)
- Health Canada. "Marketed Health Products Directorate: Retrospective - The First Five Years | 2002-2007"
 | This Canadian government–related article is a stub. You can help Wikipedia by expanding it. |